Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,580 | 4,966 | 6,320 | 6,920 | 8,160 |
| Other current assets | 420 | 142 | 300 | 540 | 450 |
| TOTAL | $5,000 | $5,243 | $6,620 | $7,460 | $8,610 |
| Non-Current Assets | |||||
| PPE Net | 370 | 13 | 640 | 640 | 640 |
| Intangibles | 0 | 191 | 0 | 0 | 0 |
| Other Non-Current Assets | 160 | 0 | 210 | 240 | 340 |
| TOTAL | $530 | $204 | $850 | $880 | $980 |
| Total Assets | $5,180 | $5,447 | $6,860 | $7,730 | $8,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 440 | 416 | 500 | 530 | 130 |
| Accrued Expenses | 380 | 181 | 740 | 1,080 | 1,330 |
| TOTAL | $830 | $901 | $1,250 | $1,610 | $1,470 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 5 |
| TOTAL | $N/A | $N/A | $N/A | $1 | $5 |
| Total Liabilities | $830 | $901 | $1,250 | $1,610 | $1,470 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 2,056 | 1,715 | 1,463 | N/A |
| Common Shares | 20 | 17 | 190 | 170 | 160 |
| Retained earnings | -227,310 | -225,432 | -223,750 | -221,510 | -219,240 |
| Other shareholders' equity | -40 | 0 | 0 | -200 | 0 |
| TOTAL | $4,340 | $4,546 | $5,610 | $6,110 | $7,510 |
| Total Liabilities And Equity | $5,170 | $5,447 | $6,860 | $7,720 | $8,980 |